Divison of Clinical Genetics, Department of Laboratory Medicine, BMC C13, Lund University, Lund, Sweden.
Department of Pathology, Karolinska University Hospital, Solna, Sweden.
Pediatr Blood Cancer. 2018 Nov;65(11):e27301. doi: 10.1002/pbc.27301. Epub 2018 Jul 3.
Wilms tumors in patients with constitutional WT1 mutations are examples of Knudson's tumor suppressor paradigm, with somatic inactivation of the second allele occurring through 11p loss of heterozygosity. The time point of this second hit has remained unknown. We analyzed seven Wilms tumors from two patients with constitutional WT1 mutations by whole exome sequencing and genomic array. All tumors exhibited wild type WT1 loss through uniparental isodisomy. Each tumor had a unique genomic breakpoint in 11p, typically accompanied by a private activating mutation of CTNNB1. Hence, convergent evolution rather than field carcinogenesis underlies multifocal tumors in WT1 mutation carriers.
患有 WT1 基因突变的患者的肾母细胞瘤是 Knudson 的肿瘤抑制因子范例的例子,第二个等位基因的体细胞失活是通过 11p 杂合性丢失发生的。第二个打击的时间点一直未知。我们通过全外显子组测序和基因组芯片分析了来自两名患有 WT1 基因突变的患者的七个肾母细胞瘤。所有肿瘤均通过单亲二倍体显示 WT1 野生型缺失。每个肿瘤在 11p 上都有独特的基因组断裂点,通常伴有 CTNNB1 的私有激活突变。因此,WT1 突变携带者的多灶性肿瘤是基于趋同进化,而不是致癌基因的弥散性激活。